Literature DB >> 25688615

Regular aspirin use does not reduce risk of cognitive decline.

Brendan J Kelley1, Leslie A McClure, Frederick W Unverzagt, Brett Kissela, Dawn Kleindorfer, George Howard, Virginia G Wadley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25688615      PMCID： PMC4339216          DOI： 10.1111/jgs.13271

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  10 in total

1.  Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study.

Authors:  C Jonker; H C Comijs; J H Smit
Journal:  Neurobiol Aging       Date:  2003 Jul-Aug       Impact factor: 4.673

2.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

3.  Risk of Alzheimer's disease and duration of NSAID use.

Authors:  W F Stewart; C Kawas; M Corrada; E J Metter
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

4.  Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Virginia G Wadley; Leslie A McClure; Virginia J Howard; Frederick W Unverzagt; Rodney C Go; Claudia S Moy; Martha R Crowther; Camilo R Gomez; George Howard
Journal:  Stroke       Date:  2007-02-22       Impact factor: 7.914

5.  Low dose aspirin and cognitive function in the women's health study cognitive cohort.

Authors:  Jae Hee Kang; Nancy Cook; JoAnn Manson; Julie E Buring; Francine Grodstein
Journal:  BMJ       Date:  2007-04-27

6.  Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

Authors:  Joan Lindsay; Danielle Laurin; René Verreault; Réjean Hébert; Barbara Helliwell; Gerry B Hill; Ian McDowell
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

7.  Report of stroke-like symptoms predicts incident cognitive impairment in a stroke-free cohort.

Authors:  Brendan J Kelley; Leslie A McClure; Abraham J Letter; Virginia G Wadley; Frederick W Unverzagt; Brett M Kissela; Dawn Kleindorfer; George Howard
Journal:  Neurology       Date:  2013-06-19       Impact factor: 9.910

8.  National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards.

Authors:  Vladimir Hachinski; Costantino Iadecola; Ron C Petersen; Monique M Breteler; David L Nyenhuis; Sandra E Black; William J Powers; Charles DeCarli; Jose G Merino; Raj N Kalaria; Harry V Vinters; David M Holtzman; Gary A Rosenberg; Anders Wallin; Martin Dichgans; John R Marler; Gabrielle G Leblanc
Journal:  Stroke       Date:  2006-08-17       Impact factor: 7.914

9.  NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type.

Authors:  C A Szekely; J C S Breitner; A L Fitzpatrick; T D Rea; B M Psaty; L H Kuller; P P Zandi
Journal:  Neurology       Date:  2007-11-14       Impact factor: 11.800

10.  Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial.

Authors:  Jackie F Price; Marlene C Stewart; Ian J Deary; Gordon D Murray; Peter Sandercock; Isabella Butcher; F Gerald R Fowkes
Journal:  BMJ       Date:  2008-09-01
  10 in total
  6 in total

Review 1.  PPARα Between Aspirin and Plaque Clearance.

Authors:  Sujyoti Chandra; Avik Roy; Dhruv R Patel; Kalipada Pahan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 2.  Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis.

Authors:  Nicola Veronese; Brendon Stubbs; Stefania Maggi; Trevor Thompson; Patricia Schofield; Christoph Muller; Ping-Tao Tseng; Pao-Yen Lin; André F Carvalho; Marco Solmi
Journal:  J Am Geriatr Soc       Date:  2017-04-20       Impact factor: 5.562

3.  Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.

Authors:  Ewa Bulzacka; Laurent Boyer; Franck Schürhoff; Ophélia Godin; Fabrice Berna; Lore Brunel; Méja Andrianarisoa; Bruno Aouizerate; Delphine Capdevielle; Isabelle Chéreau-Boudet; Gabrielle Chesnoy-Servanin; Jean-Marie Danion; Caroline Dubertret; Julien Dubreucq; Catherine Faget; Franck Gabayet; Tifenn Le Gloahec; Pierre-Michel Llorca; Jasmina Mallet; David Misdrahi; Romain Rey; Raphaëlle Richieri; Christine Passerieux; Paul Roux; Hanan Yazbek; Marion Leboyer; Guillaume Fond
Journal:  Schizophr Bull       Date:  2016-05-03       Impact factor: 9.306

Review 4.  PPARα serves as a new receptor of aspirin for neuroprotection.

Authors:  Dhruv Patel; Avik Roy; Kalipada Pahan
Journal:  J Neurosci Res       Date:  2019-12-03       Impact factor: 4.164

5.  Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα.

Authors:  Sujyoti Chandra; Malabendu Jana; Kalipada Pahan
Journal:  J Neurosci       Date:  2018-07-02       Impact factor: 6.167

Review 6.  Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke.

Authors:  Fred Stephen Sarfo; Rufus Akinyemi; George Howard; Virginia J Howard; Kolawole Wahab; Mary Cushman; Deborah A Levine; Adesola Ogunniyi; Fred Unverzagt; Mayowa Owolabi; Bruce Ovbiagele
Journal:  J Neurol Sci       Date:  2020-02-19       Impact factor: 4.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.